Cresco Labs Inc. – OTC:CRLBF
Founder-led company
Cresco Labs stock price today
$1.02
+0.17
+20.14%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 18 minutes
Cresco Labs stock price monthly change
-50.06%
month
Cresco Labs stock price quarterly change
-50.06%
quarter
Cresco Labs stock price yearly change
-38.03%
year
Cresco Labs key metrics
Market Cap | 560.90M |
Enterprise value | 986.22M |
P/E | -2.21 |
EV/Sales | 1.14 |
EV/EBITDA | 7.34 |
Price/Sales | 0.51 |
Price/Book | 0.55 |
PEG ratio | N/A |
EPS | -0.46 |
Revenue | 765.35M |
EBITDA | 136.26M |
Income | -152.51M |
Revenue Q/Q | -5.52% |
Revenue Y/Y | -6.94% |
Profit margin | -7.6% |
Oper. margin | 10.34% |
Gross margin | 49.87% |
EBIT margin | 10.34% |
EBITDA margin | 17.8% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCresco Labs stock price history
Cresco Labs stock forecast
Cresco Labs financial statements
| Jun 2023 | 197.88M | -36.53M | -18.46% |
|---|---|---|---|
| Sep 2023 | 190.55M | -113.44M | -59.53% |
| Dec 2023 | 193.43M | 2.63M | 1.36% |
| Mar 2024 | 183.47M | -5.16M | -2.82% |
| Dec 2023 | 193.43M | 2.63M | 1.36% |
|---|---|---|---|
| Mar 2024 | 183.47M | -5.16M | -2.82% |
| Sep 2025 | 202.26M | 5.12M | 2.53% |
| Dec 2025 | 205.07M | 5.12M | 2.5% |
Analysts Price target
Financials & Ratios estimates
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 0.37% |
|---|---|
| 2020 | 0.01% |
| 2021 | |
| 2022 | |
| 2023 |
| Jun 2023 | 1511231000 | 964.25M | 63.81% |
|---|---|---|---|
| Sep 2023 | 1399153000 | 973.29M | 69.56% |
| Dec 2023 | 1351516675 | 925.63M | 68.49% |
| Mar 2024 | 1358662976 | 939.12M | 69.12% |
| Jun 2023 | 17.97M | -14.05M | -19.54M |
|---|---|---|---|
| Sep 2023 | 40.62M | -12.47M | 10.05M |
| Dec 2023 | -3.23M | 2.55M | -3.89M |
| Mar 2024 | 36.30M | -5.65M | -11.09M |
Cresco Labs alternative data
| Aug 2023 | 3,200 |
|---|---|
| Sep 2023 | 3,000 |
| Oct 2023 | 3,000 |
| Nov 2023 | 3,000 |
| Dec 2023 | 3,200 |
| Jan 2024 | 3,200 |
| Feb 2024 | 3,200 |
| Mar 2024 | 2,760 |
| Apr 2024 | 2,760 |
| May 2024 | 2,760 |
| Jun 2024 | 2,800 |
| Jul 2024 | 2,800 |
Cresco Labs other data
0.04%
-0.22%
of CRLBF is owned by hedge funds
128.97K
-569.96K
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q1 2024 15 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 13 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 15 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 16 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Charles Bachtell (1979) Co-Founder, Chief Executive Officer & Director | $537,500 |
Mr. Dennis M. Olis (1963) Chief Financial Officer | $202,120 |
Curaleaf Has More Risk Than Peers
The Cannabist Company Makes Sense To Buy Again
The Sustainability Of Cannabis Bull Run
Green Thumb: Best House In A Bad Neighborhood
Finding The Long-Term Winners In The Cannabis Sector
Green Thumb Industries: My Strongest Conviction Pick In The Cannabis Industry
Troubled Trulieve Is A Timely Buy
Cresco Labs: An Unloved U.S. Cannabis Multi-State Operator
Cannabis Company Columbia Care Is A Bargain
-
What's the price of Cresco Labs stock today?
One share of Cresco Labs stock can currently be purchased for approximately $1.02.
-
When is Cresco Labs's next earnings date?
Unfortunately, Cresco Labs's (CRLBF) next earnings date is currently unknown.
-
Does Cresco Labs pay dividends?
No, Cresco Labs does not pay dividends.
-
How much money does Cresco Labs make?
Cresco Labs has a market capitalization of 560.90M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8.52% to 770.89M US dollars.
-
What is Cresco Labs's stock symbol?
Cresco Labs Inc. is traded on the OTC under the ticker symbol "CRLBF".
-
What is Cresco Labs's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Cresco Labs?
Shares of Cresco Labs can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cresco Labs's key executives?
Cresco Labs's management team includes the following people:
- Mr. Charles Bachtell Co-Founder, Chief Executive Officer & Director(age: 46, pay: $537,500)
- Mr. Dennis M. Olis Chief Financial Officer(age: 62, pay: $202,120)
-
Is Cresco Labs founder-led company?
Yes, Cresco Labs is a company led by its founder Mr. Charles Bachtell.
-
How many employees does Cresco Labs have?
As Jul 2024, Cresco Labs employs 2,800 workers, which is 1% more then previous quarter.
-
When Cresco Labs went public?
Cresco Labs Inc. is publicly traded company for more then 6 years since IPO on 3 Dec 2018.
-
What is Cresco Labs's official website?
The official website for Cresco Labs is crescolabs.com.
-
Where are Cresco Labs's headquarters?
Cresco Labs is headquartered at 400 West Erie Street, Chicago, IL.
-
How can i contact Cresco Labs?
Cresco Labs's mailing address is 400 West Erie Street, Chicago, IL and company can be reached via phone at +31 29290993.
Cresco Labs company profile:
Cresco Labs Inc.
crescolabs.comExchange:
OTC
Full time employees:
3,300
Industry:
Drug Manufacturers—Specialty & Generic
Sector:
Healthcare
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was founded in 2013 and is headquartered in Chicago, Illinois.
400 West Erie Street
Chicago, IL 60654
Chicago, IL 60654
CIK: 0001832928
ISIN: CA22587M1068
:
